Questcor Has Had An Incredible Run: Cramer

[cnbc 3000114481]

Questcor Pharmaceuticals is not your typical controversial biotech stock — it’s a stock that has rallied from $0.50 in 2005 to $52 today on the strength of its single product called “Acthar Gel,” says Mad Money host Jim Cramer.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.